Attention Deficit Disorders

[P051] Effects of atomoxetine on the mPFC of SHRSP/Ezo as an ADHD animal model

*Hiroki Shikanai^1,2, Naoya Suzuki¹, Satoshi Shinozuka¹, Takeru Isshiki¹, Sachiko Hiraide¹, Kenji Iizuka¹, Takeshi Izumi^1,2, Taku Yamaguchi³ (1. Department of Pharmacology, Faculty of Pharmaceutical Sciences, Health Science University of Hokkaido, Hokkaido, Japan, 2. Advanced Research Promotion Center, Health Science University of Hokkaido, Hokkaido, Japan, 3. Department of Pharmacotherapeutics and Neuropsychopharmacology, Faculty of Pharmaceutical Science, Nagasaki International University, Nagasaki, Japan)

Keywords:Attention-deficit/hyperactivity disorder, stroke-prone spontaneously hypertensive rats (SHRSP/Ezo), Noradrenaline transporter inhibitor, medial prefrontal cortex